Gene Activity List


Gene Activity List

Gene Compound Assay Inh Ic50 Ki View
gamma-aminobutyric acid A receptor, alpha 2 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 FLEROXACIN GABAA, Agonist Site -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 MYCOPHENOLATE MOFETIL Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel associated protein 1 FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel associated protein 2 FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
amiloride-sensitive cation channel 5, intestinal FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VIII, alpha polypeptide FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha FLUORESCEIN Sodium Channel, Site 2 -16% NoneNone NoneNone View
calcium channel, voltage-dependent, beta 1 subunit DIFLUNISAL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, L type, alpha 1E subunit DIFLUNISAL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, N type, alpha 1B subunit DIFLUNISAL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
calcium channel, voltage-dependent, alpha2/delta subunit 1 DIFLUNISAL Calcium Channel Type L, Phenylalkylamine -16% NoneNone NoneNone View
opioid receptor, sigma 1 DIFLUNISAL Sigma1 -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 5 (DBSS) CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 1b CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 1a CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 4 CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 11b (osteoprotegerin) CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 8 CYTARABINE Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
natriuretic peptide receptor 2 CITRININ Atrial Natriuretic Factor (ANF) -16% NoneNone NoneNone View
guanylate cyclase A/atrial natriuretic peptide receptor (Non-specific probe) CITRININ Atrial Natriuretic Factor (ANF) -16% NoneNone NoneNone View
natriuretic peptide receptor 3 CITRININ Atrial Natriuretic Factor (ANF) -16% NoneNone NoneNone View
cholinergic receptor, muscarinic 4 CITRININ Muscarinic M4 -16% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA1 (alpha 1) DICYCLOMINE Glutamate, AMPA -16% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA2 DICYCLOMINE Glutamate, AMPA -16% NoneNone NoneNone View
glutamate receptor, ionotropic, AMPA3 (alpha 3) DICYCLOMINE Glutamate, AMPA -16% NoneNone NoneNone View
glutamate receptor subunit 4c DICYCLOMINE Glutamate, AMPA -16% NoneNone NoneNone View
adenosine A1 receptor ATROPINE Adenosine A1 -16% NoneNone NoneNone View
FMS-like tyrosine kinase 1 FUROSEMIDE Vascular Endothelinal Growth Factor (VEGF) -16% NoneNone NoneNone View
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) FUROSEMIDE Vascular Endothelinal Growth Factor (VEGF) -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta SULINDAC Sodium Channel, Site 2 -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 CLOTRIMAZOLE Potassium Channel [KATP] -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 CLOTRIMAZOLE Potassium Channel [KATP] -16% NoneNone NoneNone View
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 CLOTRIMAZOLE Potassium Channel [KATP] -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) BETA-ESTRADIOL 3-BENZOATE Cyclooxygenase COX-1 -16% NoneNone NoneNone View
lymphocyte protein tyrosine kinase (mapped) AMANTADINE Protein Tyrosine Kinase, Lck -16% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific AMIFOSTINE Phosphodiesterase PDE5 -16% NoneNone NoneNone View
phosphodiesterase 5A, cGMP-specific AMIFOSTINE Phosphodiesterase PDE5 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 10, alpha polypeptide AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha polypeptide AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha polypeptide AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 gamma AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 beta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type 2, alpha 1 polypeptide AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type XI, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, gamma AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, delta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, nonvoltage-gated 1 alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type X, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IX, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage gated, type VIII, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type VII, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, beta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type IV, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type III, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, beta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type II, alpha 2 AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, beta AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
sodium channel, voltage-gated, type I, alpha AMIFOSTINE Sodium Channel, Site 2 -16% NoneNone NoneNone View
protein phosphatase 3 (formerly 2B), catalytic subunit, alpha isoform (calcineurin A alpha) AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform (calcineurin A beta) AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform (calcineurin A gamma) AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
protein phosphatase 3, catalytic subunit, beta isoform AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
bM410K19.2.2 (novel protein similar to extra-cellular matrix proteins and chondroitin sulfate proteoglycans, variant 2) (DBSS) AMIFOSTINE Protein Serine/Threonine Phosphatase, Calcineurin PP2B -16% NoneNone NoneNone View
tumor necrosis factor receptor superfamily, member 8 LIPOPOLYSACCHARIDE E. COLI O55:B5 Tumor Necrosis Factor (TNF), Non-Selective -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3a LACTIC ACID Serotonin 5-HT3 -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 3b LACTIC ACID Serotonin 5-HT3 -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 5B BETAMETHASONE Serotonin 5-HT4 -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 4 BETAMETHASONE Serotonin 5-HT4 -16% NoneNone NoneNone View
glycine receptor, alpha 3 ALPRAZOLAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 1 subunit ALPRAZOLAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, beta subunit ALPRAZOLAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
glycine receptor, alpha 2 subunit ALPRAZOLAM Glycine, Strychnine-Sensitive -16% NoneNone NoneNone View
histamine receptor H 1 4-OCTYLPHENOL Histamine H1, Central -16% NoneNone NoneNone View
melanocortin 5 receptor BIS(2-ETHYLHEXYL)PHTHALATE Melanocortin MC5 -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 4 TROMETHAMINE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 3 TROMETHAMINE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 2 TROMETHAMINE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 1 TROMETHAMINE Glutamate, Kainate -16% NoneNone NoneNone View
glutamate receptor, ionotropic, kainate 5 TROMETHAMINE Glutamate, Kainate -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 2B PROGESTERONE Serotonin 5-HT2B -16% NoneNone NoneNone View
thromboxane A synthase 1 BIS(2-ETHYLHEXYL)PHTHALATE Thromboxane Synthetase -16% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) BIS(2-ETHYLHEXYL)PHTHALATE Thromboxane Synthetase -16% NoneNone NoneNone View
leukotriene B4 receptor 2 MESTRANOL Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor MESTRANOL Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor MESTRANOL Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor 2 MESTRANOL Leukotriene B4 -16% NoneNone NoneNone View
insulin receptor BIS(2-ETHYLHEXYL)PHTHALATE Insulin -16% NoneNone NoneNone View
insulin receptor BIS(2-ETHYLHEXYL)PHTHALATE Insulin -16% NoneNone NoneNone View
matrix metalloproteinase 1 (interstitial collagenase) CAPTOPRIL Protease, Matrix Metalloprotease-1 (MMP-1) -16% NoneNone NoneNone View
adrenergic receptor, alpha 1a 3-ACETAMIDOPHENOL Adrenergic alpha1A -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2D ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
glutamate receptor, ionotropic, NMDA2C ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2B ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl D-aspartate 2A ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B ALTRETAMINE Glutamate, NMDA, Phencyclidine -16% NoneNone NoneNone View
prostaglandin-endoperoxide synthase 1 BETA-ESTRADIOL 3-BENZOATE Cyclooxygenase COX-1 -16% NoneNone NoneNone View
leukotriene B4 receptor PREDNISONE Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor 2 PREDNISONE Leukotriene B4 -16% NoneNone NoneNone View
interleukin 8 receptor, beta CIPROFIBRATE Chemokine CXCR2 (IL-8B) -16% NoneNone NoneNone View
cholinergic receptor, muscarinic 5 MICONAZOLE Muscarinic M5 -16% NoneNone NoneNone View
monoamine oxidase A VANCOMYCIN Monoamine Oxidase MAOA -16% NoneNone NoneNone View
monoamine oxidase A VANCOMYCIN Monoamine Oxidase MAOA -16% NoneNone NoneNone View
5-hydroxytryptamine (serotonin) receptor 1A PIMARICIN Serotonin 5-HT1A -16% NoneNone NoneNone View
thromboxane A synthase 1 FLUOROURACIL Thromboxane Synthetase -16% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) FLUOROURACIL Thromboxane Synthetase -16% NoneNone NoneNone View
thromboxane A synthase 1 INDOMETHACIN Thromboxane Synthetase -16% NoneNone NoneNone View
thromboxane A synthase 1 (platelet, cytochrome P450, family 5, subfamily A) INDOMETHACIN Thromboxane Synthetase -16% NoneNone NoneNone View
adrenergic receptor, beta 1 METYRAPONE Adrenergic beta1 -16% NoneNone NoneNone View
adrenergic, beta-1-, receptor METYRAPONE Adrenergic beta1 -16% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 1 BENZO[A]PYRENE Purinergic P2X -16% NoneNone NoneNone View
purinergic receptor P2X, ligand-gated ion channel, 7 BENZO[A]PYRENE Purinergic P2X -16% NoneNone NoneNone View
purinergic receptor P2X-like 1, orphan receptor BENZO[A]PYRENE Purinergic P2X -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 1 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, pi FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
AT hook, DNA binding motif, containing 1 (DBSS) FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, theta FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, gamma 2 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 2 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, alpha 1 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid A receptor, delta FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 FENOFIBRATE GABAA, Agonist Site -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 10 METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, epsilon polypeptide METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 4 METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 5 METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 ERGOCORNINE Serotonin Transporter -16% NoneNone NoneNone View
cholinergic receptor, nicotinic, alpha polypeptide 9 METHOTREXATE Nicotinic Acetylcholine, Central -16% NoneNone NoneNone View
arginine vasopressin receptor 1A Y-27632 Vasopressin V1A -16% NoneNone NoneNone View
leukotriene B4 receptor 2 BUDESONIDE Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor BUDESONIDE Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor BUDESONIDE Leukotriene B4 -16% NoneNone NoneNone View
leukotriene B4 receptor 2 BUDESONIDE Leukotriene B4 -16% NoneNone NoneNone View
interleukin 8 receptor, beta ACETAZOLAMIDE Chemokine CXCR2 (IL-8B) -16% NoneNone NoneNone View
cannabinoid receptor 1 (brain) ALPHA-TOCOPHEROL Cannabinoid CB1 -16% NoneNone NoneNone View
chemokine (C-C motif) receptor 4 ACETAZOLAMIDE Chemokine CCR4 -16% NoneNone NoneNone View
cholinergic receptor, muscarinic 2 (+)-THALIDOMIDE Muscarinic M2 -16% NoneNone NoneNone View
monoamine oxidase A CYCLOPHOSPHAMIDE Monoamine Oxidase MAOA -16% NoneNone NoneNone View
monoamine oxidase A CYCLOPHOSPHAMIDE Monoamine Oxidase MAOA -16% NoneNone NoneNone View
acetylcholinesterase (YT blood group) CYCLOHEXIMIDE Acetylcholinesterase -16% NoneNone NoneNone View
collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase CYCLOHEXIMIDE Acetylcholinesterase -16% NoneNone NoneNone View
acetylcholinesterase CYCLOHEXIMIDE Acetylcholinesterase -16% NoneNone NoneNone View